Treatment of atopic eczema with oral mycophenolate mofetil
- 1 August 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (2), 385-391
- https://doi.org/10.1046/j.1365-2133.2000.03667.x
Abstract
Background Activated T and B lymphocytes are the predominant inflammatory cells in atopic eczema (AE) lesions. Mycophenolic acid, the active form of mycophenolate mofetil (MMF), blocks the prolifera...Keywords
This publication has 29 references indexed in Scilit:
- Mycophenolic acid in psoriasisBritish Journal of Dermatology, 2006
- Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential usesJournal of the American Academy of Dermatology, 1997
- Staphylococcal Enterotoxin B Affects in vitro IgE Synthesis, Interferon-γ, lnterleukin-4 and lnterleukin-5 Production in Atopic EczemaInternational Archives of Allergy and Immunology, 1995
- Systemic interferon gamma treatment in severe atopic dermatitisJournal of the American Academy of Dermatology, 1993
- Interleukin-10Annual Review of Immunology, 1993
- A Simple Testing Procedure “Control versus k Treatments” for One‐sided Ordered Alternatives, with Application in ToxicologyBiometrical Journal, 1991
- Management of patients and side effects during cyclosporine therapy for cutaneous disordersJournal of the American Academy of Dermatology, 1990
- Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production.The Journal of Experimental Medicine, 1990
- Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γEuropean Journal of Immunology, 1990
- Mycophenolic acid for psoriasisJournal of the American Academy of Dermatology, 1987